We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$505M
AUM Growth
+$162M
Cap. Flow
+$166M
Cap. Flow %
32.79%
Top 10 Hldgs %
36.69%
Holding
110
New
32
Increased
27
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$19.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$16.9M
3
AMN icon
AMN Healthcare
AMN
+$14.3M
4
CI icon
Cigna
CI
+$14.3M
5
ALBO
Albireo Pharma Inc
ALBO
+$13.9M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.84M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$8.57M
3
RCM
R1 RCM Inc. Common Stock
RCM
+$8.51M
4
LLY icon
Eli Lilly
LLY
+$7.54M
5
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$6.16M

Sector Composition

Rank Sector Weight
1 Healthcare 74.38%
2 Consumer Staples 0.82%
3 Financials 0.57%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCM
101
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-763,023
Closed -$8.51M
MORF
102
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-45,386
Closed -$1.23M
FUSN
103
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-3,000
Closed -$52K
ARAV
104
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-68,373
Closed -$796K
VAPO
105
DELISTED
Vapotherm, Inc. Common Stock
VAPO
– –
-9,494
Closed -$3.11M
ZYNE
106
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-629,000
Closed -$2.12M
BLCM
107
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-7,751
Closed -$58K
TRIL
108
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-86,757
Closed -$702K
KDMN
109
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-52,500
Closed -$269K
BMY.RT
110
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-1,719,271
Closed -$6.16M
1 2 3 4
5

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return
ACM
Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return

Sio Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Sio Capital Management held 110 positions worth $505M, up 47% from $343M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sio Capital Management deployed $166M of net new capital in Q3 2020, opening 32 new positions and adding to 27 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 194,744 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 76% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was GW Pharmaceuticals Plc American Depositary Shares, an estimated $8.57M trimmed.

  • Sio Capital Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 194,744 shares worth $14.8M.
  • Sio Capital Management added most to HILL-ROM HOLDINGS, INC. in Q3 2020, an estimated $10.8M increase.
  • Sio Capital Management's biggest Q3 2020 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $8.57M.
  • Sio Capital Management fully exited Merck in Q3 2020, selling an estimated $8.84M.
  • Sio Capital Management's ten largest holdings make up 37% of its $505M portfolio in Q3 2020.
  • Sio Capital Management opened 32 new positions and closed 21 in Q3 2020.
  • Sio Capital Management's portfolio value rose 47% quarter-over-quarter to $505M.

Based on Sio Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.